CLOBEMIX

This brand name is authorized in Australia

Active ingredients

The drug CLOBEMIX contains one active pharmaceutical ingredient (API):

1 Moclobemide UNII PJ0Y7AZB63 - MOCLOBEMIDE
Moclobemide is an antidepressant which affects the monoaminergic cerebral neurotransmitter system by means of a reversible inhibition of monoamine oxidase preferentially of type A (RIMA). Read about Moclobemide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06AG02	Moclobemide	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AG Monoamine oxidase A inhibitors
Discover more medicines within N06AG02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1900B, 8003F

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.